Article Versions Notes

Ou S-H, Yin C-H, Chung T-L, Chen H-Y, Chen C-L, Chen J-S, Lee P-T. Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy. International Journal of Environmental Research and Public Health. 2022; 19(21):14298. https://doi.org/10.3390/ijerph192114298

Ou, Shih-Hsiang, Chun-Hao Yin, Tung-Ling Chung, Hsin-Yu Chen, Chien-Liang Chen, Jin-Shuen Chen, and Po-Tsang Lee. 2022. "Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy" International Journal of Environmental Research and Public Health 19, no. 21: 14298. https://doi.org/10.3390/ijerph192114298

Ou, S.-H., Yin, C.-H., Chung, T.-L., Chen, H.-Y., Chen, C.-L., Chen, J.-S., & Lee, P.-T. (2022). Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy. International Journal of Environmental Research and Public Health, 19(21), 14298. https://doi.org/10.3390/ijerph192114298